Proton Intelligence develops wearable potassium monitor with $6.95m seed funding

2 months ago
17 Views

Proton Intelligence, a Canadian startup, has raised $6.95 million in a seed round to develop a wearable device for continuous potassium monitoring. The device, which will be inserted just under the skin, will connect to a smartphone app, allowing patients to track potassium levels and receive alerts if they fall out of a safe range. The product, currently in clinical trials, is expected to launch in 2025.

The company’s solution aims to address the life-threatening challenges of potassium imbalances, which are particularly dangerous for those with chronic kidney disease or at risk of heart failure. Proton’s device also includes a clinician dashboard, enabling healthcare providers to monitor trends and adjust therapies.

Proton was co-founded by CEO Sahan Ranamukhaarachchi and CSO Victor Cadarso, who both have extensive backgrounds in wearable biosensors. Ranamukhaarachchi emphasised that the device could prevent hospitalisations and sudden cardiac deaths by offering continuous monitoring, a critical step in managing potassium levels.

The startup faces competition from other companies in the space, such as AliveCor, Alio, and Renalyse, but Proton claims its technology offers superior accuracy and usability. The seed funding round was led by SOSV, with additional support from We Venture Capital, Tenmile, LongeVC, and others.…Read more by iliasd@diplomacy.edu

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

IJNN

FREE
VIEW